Wilmette, IL, United States of America

Yilin Zhang

USPTO Granted Patents = 3 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):

Title: Yilin Zhang: Innovator in Therapeutic Sensitivity Prediction

Introduction

Yilin Zhang is an accomplished inventor based in Wilmette, IL (US). He has made significant contributions to the field of therapeutic sensitivity prediction, holding a total of 3 patents. His work focuses on utilizing organoid cultures to enhance treatment predictions and outcomes.

Latest Patents

Yilin Zhang's latest patents include innovative systems and methods for predicting therapeutic sensitivity. These methods, systems, and software leverage organoid cultures, particularly patient-derived tumor organoid cultures, to improve treatment predictions and outcomes. Another notable patent is centered on large-scale organoid analysis, which also aims to enhance treatment predictions and outcomes through similar methodologies.

Career Highlights

Throughout his career, Yilin Zhang has worked with prominent companies such as Tempus Labs, Inc. and Tempus AI, Inc. His expertise in organoid cultures and therapeutic sensitivity has positioned him as a key figure in the research and development of advanced treatment methodologies.

Collaborations

Yilin has collaborated with talented individuals in his field, including Ameen Salahudeen and Verónica Sánchez Freire, who is a notable woman in the industry.

Conclusion

Yilin Zhang's innovative work in therapeutic sensitivity prediction through organoid cultures showcases his dedication to improving treatment outcomes. His contributions are paving the way for advancements in personalized medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…